Considerations for Psychosocial Treatment
- Treatment planning should anticipate circumstances in which participants do not adhere to recommended plans for, or referrals to, psychosocial treatment. This includes renegotiation of the treatment plan between the participant and the clinician, and involvement of other team members to achieve compliance and engagement.
- While essential for the typical treatment court participant to mitigate criminogenic risk and support recovery management, psychosocial treatment, including recurrence prevention, is not necessary to begin any form of medication for OUD, including extended-release naltrexone. Refer to the 2020 ASAM guideline for the treatment of OUD and SAMHSA TIP 63, Medications for Opioid Use Disorder.
